Invest now
Caplin Point Laboratories Balance Sheet Annual
BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs2,415.00 -44.55 (-1.81%)Updated : 12 Oct 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 4,045.48 | 3,207.85 | 2,698.12 | 2,191.40 |
| Accumulated Depreciation Total | -368.75 | -300.73 | -239.57 | -192.88 |
| Cash Equivalents | 0.00 | 59.00 | 49.03 | 82.05 |
| Other Liabilities Total | 14.06 | 12.56 | 19.09 | 15.20 |
| Accrued Expenses | 36.44 | 34.55 | 25.30 | 8.47 |
| Common Stock Total | 15.20 | 15.20 | 15.19 | 15.18 |
| Other Equity Total | 387.81 | 246.17 | 219.10 | 207.65 |
| Other Current Assets Total | 14.99 | 8.82 | 10.57 | 60.02 |
| Prepaid Expenses | 15.80 | 13.60 | 1.80 | - |
| Total Assets | 4,045.48 | 3,207.85 | 2,698.12 | 2,191.40 |
| Current Portof LT Debt/ Capital Leases | 2.55 | 2.11 | 1.05 | 4.55 |
| Additional Paid- In Capital | 19.36 | 19.36 | 15.41 | 13.41 |
| Cash | 86.64 | 134.74 | 89.52 | 88.87 |
| Total Equity | 3,586.42 | 2,850.49 | 2,315.71 | 1,880.48 |
| Long Term Investments | 482.32 | 286.29 | 137.64 | 70.91 |
| Retained Earnings( Accumulated Deficit) | 3,071.17 | 2,475.53 | 1,977.21 | 1,554.29 |
| Total Common Shares Outstanding | 7.60 | 7.60 | 7.59 | 7.59 |
| Property/ Plant/ Equipment Total- Gross | 1,128.51 | 974.46 | 796.33 | 682.23 |
| Tangible Book Valueper Share Common Eq | 464.74 | 372.96 | 303.28 | 246.28 |
| Goodwill Net | 20.91 | 8.50 | 2.77 | 2.77 |
| Total Liabilities | 459.06 | 357.36 | 382.41 | 310.92 |
| Total Debt | 4.61 | 5.02 | 1.97 | 5.48 |
| Short Term Investments | 905.12 | 700.79 | 642.15 | 472.72 |
| Cashand Short Term Investments | 991.76 | 894.53 | 780.70 | 643.64 |
| Total Receivables Net | 1,134.25 | 880.90 | 736.81 | 562.58 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Tax | 12.60 | - | - | - |
| Accounts Receivable- Trade Net | 882.79 | 669.32 | 562.36 | 419.58 |
| Property/ Plant/ Equipment Total- Net | 759.76 | 673.73 | 556.76 | 489.35 |
| Minority Interest | 44.38 | 35.90 | 31.12 | 26.79 |
| Total Current Liabilities | 385.96 | 305.99 | 331.28 | 268.00 |
| Total Inventory | 428.86 | 336.10 | 363.04 | 288.22 |
| ESOP Debt Guarantee | 18.30 | 19.65 | 14.22 | 15.37 |
| Accounts Payable | 296.03 | 217.58 | 209.41 | 164.37 |
| Other Currentliabilities Total | 50.94 | 51.75 | 95.52 | 90.61 |
| Total Long Term Debt | 2.06 | 2.91 | 0.92 | 0.93 |
| Intangibles Net | 32.92 | 7.05 | 9.75 | 8.40 |
| Other Long Term Assets Total | 22.53 | 77.75 | 80.08 | 62.02 |
| Note Receivable- Long Term | 141.38 | 20.58 | 18.20 | 3.49 |
| Unrealized Gain( Loss) | 74.58 | 74.58 | 74.58 | 74.58 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 2,585.66 | 2,133.95 | 1,892.92 | 1,554.46 |
| Capital Lease Obligations | 2.06 | 2.91 | 0.92 | 0.93 |
*All figures in crores except per share values
Caplin Point Laboratories Quick Links
Caplin Point Laboratories Dividend Caplin Point Laboratories Bonus Caplin Point Laboratories News Caplin Point Laboratories AGM Caplin Point Laboratories Rights Caplin Point Laboratories Splits Caplin Point Laboratories Board Meetings Caplin Point Laboratories Key Metrics Caplin Point Laboratories Shareholdings Caplin Point Laboratories Profit Loss Caplin Point Laboratories Cashflow Caplin Point Laboratories Q1 Results Caplin Point Laboratories Q2 Results Caplin Point Laboratories Q3 Results Caplin Point Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,035.00+40.00(4.02%)
2,079.30+29.30(1.43%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)
2,851.05-96.35 (-3.27%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.